Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Orders are typically processed and dispatched within 1-3 business days of order confirmation and payment clearance
KDM4B as a target for prostate cancer: structural analysis and selective inhibition by a novel inhibitor
J Contemp Chiropr
Physical activity during the coronavirus (COVID-19) pandemic: prevention of a decline in metabolic and immunological functions
[7] PharmaCotherapia d.o.o., Phase I, Pilot Study in Healthy Volunteers, to Assess the Safety and Pharmacokinetics of PCO-02, Which Active Ingredient is BPC-157, a Penta-deca-peptide From Gastric Source., clinicaltrials.gov, Clinical trial registration NCT02637284, Dec
US$ 27.36
US$ 23.04
US$ 20.08
